Most prior longitudinal studies of GBA1-PD have employed prevalent cohorts in which variation in disease duration may confound the results, and many other studies have used clinic-based cohorts that may be disproportionately represented by atypical or severe cases. Here, GBA1 is linked to Parkinson disease.